LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Strona główna・Stock List・Pfizer

Pfizer

Open

Sector Healthcare

27.75 -1.07

Buy Sell

Overview

Share price change

24h

Current

Min

27.75

Max

28.08

Key metrics
By Trading Economics
Income	4.4B 4.5B
Sales	4.4B 18B
P/E Sector Avg	15.73 104.138
EPS	1.06
Dividend yield	5.805
Profit margin	25.226
Employees	88,000
EBITDA	4.4B 6.9B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+15.27 upside

Dividends
By Dow Jones
Dividend yield Sector Avg	5.80% 1.72%
Next Earnings	28 sty 2025
Next Dividend date	2 gru 2024
Next Ex Dividend date	8 lis 2024

Market Stats
By TradingEconomics
Market Cap	-170M 161B
Previous open	28.82
Previous close	27.75

News Sentiment

By Acuity

80%

20%

362 / 390 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

28.025 / 28.5 Support & Resistance

Pfizer Chart

Past performance is not a reliable indicator of future results.

Related News

29 paź 2024, 18:29 UTC

Earnings

Trending: Pfizer Raises Guidance After Strong 3Q

29 paź 2024, 19:19 UTC

Top News

Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts -- 5th Update

29 paź 2024, 16:04 UTC

Top News

Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts -- 4th Update

29 paź 2024, 14:12 UTC

Top News

Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts -- 3rd Update

29 paź 2024, 14:04 UTC

Top News

Earnings

Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts -- 2nd Update

29 paź 2024, 13:37 UTC

Earnings

Pfizer Earnings Beat Expectations. It's Not Enough to Ease Investor Discontent -- Barrons.com

29 paź 2024, 13:35 UTC

Earnings

Pfizer Earnings Beat Expectations. It's Not Enough to Ease Investor Discontent -- Barrons.com

29 paź 2024, 12:34 UTC

Top News

Earnings

Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts -- Update

29 paź 2024, 12:17 UTC

Earnings

Pfizer Stock Rises After Earnings. Why It Could Signal a Turnaround. -- Barrons.com

29 paź 2024, 11:32 UTC

Earnings

Pfizer Stock Rises After Earnings Beat, Guidance Hike -- Barrons.com

29 paź 2024, 11:29 UTC

Top News

Earnings

Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts -- WSJ

29 paź 2024, 11:06 UTC

Earnings

Pfizer Earnings Top Q3 Views; Pharma Giant Guides Higher -- IBD

29 paź 2024, 10:56 UTC

Top News

Earnings

Pfizer Stock Rises After Earnings Beat, Guidance Hike -- Barrons.com

29 paź 2024, 10:52 UTC

Earnings

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2024 >PFE

29 paź 2024, 10:51 UTC

Earnings

Pfizer Had Seen 2024 Revenue $59.5B-$62.5B >PFE

29 paź 2024, 10:51 UTC

Earnings

Pfizer Had Seen 2024 Adjusted EPS $2.45-$2.65 >PFE

29 paź 2024, 10:50 UTC

Earnings

Pfizer Still Sees 2024 Operational Revenue Growth of 9%-11% >PFE

29 paź 2024, 10:50 UTC

Earnings

Pfizer: Updated 2024 Revenue Guidance Includes About $10.5B for Comirnaty, Paxlovid >PFE

29 paź 2024, 10:49 UTC

Earnings

Pfizer: On Track for Net Cost Savings of at Least $5.5B From Cost-Reduction Initiatives >PFE

29 paź 2024, 10:48 UTC

Earnings

Pfizer 3Q Revenue Up 14% Operationally Excluding Contributions From Paxlovid, Comirnaty >PFE

29 paź 2024, 10:47 UTC

Earnings

Pfizer 3Q Net $4.47B >PFE

29 paź 2024, 10:45 UTC

Earnings

Pfizer Sees FY Adj EPS $2.75-Adj EPS $2.95 >PFE

29 paź 2024, 10:45 UTC

Earnings

Pfizer 3Q Adj EPS $1.06 >PFE

29 paź 2024, 10:45 UTC

Earnings

Pfizer 3Q EPS 78c >PFE

29 paź 2024, 10:45 UTC

Earnings

Pfizer 3Q Rev $17.7B >PFE

29 paź 2024, 10:45 UTC

Earnings

Pfizer Sees FY Rev $61B-$64B >PFE

29 paź 2024, 10:43 UTC

Top News

PayPal, Pfizer, McDonald's Earnings in Spotlight -- WSJ

29 paź 2024, 09:03 UTC

Hot Stocks

Stocks to Watch Tuesday: McDonald's, Ford, Trump Media -- WSJ

28 paź 2024, 20:30 UTC

Top News

Earnings

Pfizer Has a Chance to Quiet Critics When It Reports Earnings -- Barrons.com

28 paź 2024, 13:48 UTC

Earnings

Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com

Peer Comparison

Price change

Pfizer Forecast

Price Target

By TipRanks

15.27% upside

12 Months Forecast

Average 32.38 USD 15.27%

High 45 USD

Low 27 USD

Based on 20 Wall Street analysts offering 12 month price targets forPfizer - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

20 ratings

Buy

Hold

Sell

Based on 20 analysts giving stock ratings to Pfizer - Dist in the past 3 months.

Technical Score

By Trading Central

28.025 / 28.5Support & Resistance

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

362 / 390 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.